Language selection

Search

Patent 2254625 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2254625
(54) English Title: A PROCESS FOR MAKING N-(4-FLUOROPHENYL)-N-(1-METHYLETHYL)-2-[(5-TRIFLUOROMETHYL)-1,3,4-THIADIAZOL-2-YL)OXY]ACETAMIDE USING AN APROTIC, AROMATIC SOLVENT
(54) French Title: PROCEDE POUR L'OBTENTION DU N-(4-FLUOROPHENYLE)-N-(1-METHYLETHYLE)-2- [(5-TRIFLUOROMETHYLE)-1,3,4-THIADIAZOLE-2-YL)OXYACETAMIDE EN UTILISANT UN SOLVANT APROTIQUE ET AROMATIQUE
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07D 28/13 (2006.01)
  • C07D 28/12 (2006.01)
(72) Inventors :
  • PRASAD, VIDYANATHA A. (United States of America)
  • NEWALLIS, PETER E. (United States of America)
  • WASLESKI, DANIEL M. (United States of America)
  • APPLEGATE, JACQUELINE M. (Germany)
  • JELICH, KLAUS (United States of America)
(73) Owners :
  • BAYER CORPORATION
(71) Applicants :
  • BAYER CORPORATION (United States of America)
(74) Agent: NORTON ROSE FULBRIGHT CANADA LLP/S.E.N.C.R.L., S.R.L.
(74) Associate agent:
(45) Issued:
(22) Filed Date: 1998-11-27
(41) Open to Public Inspection: 1999-06-12
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
08/989,597 (United States of America) 1997-12-12

Abstracts

English Abstract


The present invention relates to a process for making
N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thiadiazol-2-
yl)oxy]acetamide in an aprotic, aromatic solvent. The process includes
the steps of: (a) reacting 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-
thiadiazole with N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide
in the presence of an aprotic, aromatic solvent to form an aqueous phase
and an organic phase; (b) acidifying the phases, (c) separating the
phases; and (d) recovering the N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-
trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy]acetamide from the organic
phase.


Claims

Note: Claims are shown in the official language in which they were submitted.


-16-
The embodiments of the invention in which an exclusive
property or privilege is claimed are defined as follows:-
1. A process for preparing N-(4-fluorophenyl)-N-(1-methyl-
ethyl)-2-[(5-trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy]acetamide comprising
the steps of:
(a) reacting 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-
thiadiazole with N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide
in the presence of an aprotic, aromatic solvent to form an aqueous phase
and an organic phase;
(b) acidifying the mixture
(c) separating the phases and
(d) recovering the N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-
trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy]acetamide from the organic
phase.
2. The process of Claim 1 wherein the solvent is toluene,
xylene, cumene or mesitylene.
3. The process of Claim 2 wherein the solvent is toluene.
4. The process of Claim 1 wherein reaction occurs in the
presence of an aqueous alkali.
5. The process of Claim 4 wherein the aqueous alkali is an
aqueous alkali metal carbonate or an aqueous alkali metal hydroxide.
6. The process of Claim 5 wherein the alkali metal is sodium.
7. The process of Claim 5 wherein the alkali metal hydroxide
is sodium hydroxide.
8. The process of Claim 1 wherein the aqueous phase has a
pH of from about 8 to about 14.
9. The process of Claim 8 wherein the aqueous phase has a
pH of from about 12 to about 14.
10. The process of Claim 9 wherein the aqueous phase has a
pH of about 13.

-17-
11. The process of Claim 1 wherein 2-(methylsulfonyl)-5-
(trifluoromethyl)-1,3,4-thiadiazole in toluene is mixed with
N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide in toluene and
aqueous alkali is added at a temperature of from about 0°C to about
30°C.
12. The process of Claim 11 wherein the temperature is from
about 5°C to about 15°C.
13. The process of Claim 12 wherein the temperature is from
about 5°C to about 10°C.
14. The process of Claim 1 wherein the molar ratio of
2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole to N-(4-fluorophenyl)-
2-hydroxy-N-(1-methylethyl)acetamide is from about 1.5:1 to about 1:1.5.
15. The process of Claim 15 wherein the molar ratio of solvent
to 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole is from about 1:1
to about 5:1.
16. The process of Claim 4 further comprising the step of
acidifying the reaction mixture prior to step (c) of Claim 1.
17. The process of Claim 16 wherein the pH of the reaction
mixture is adjusted to a pH of from about 1.0 to about 6Ø
18. The process of Claim 17 wherein the pH is from about 2.0
to about 5Ø
19. The process of Claim 16 wherein the reaction mixture is
treated with hydrochloric acid or sulfuric acid.
20. The process of Claim 16 wherein the reaction mixture is
heated to a temperature of from about 10°C to about 90°C after
acidification.
21. The process of Claim 20 wherein the reaction mixture is
heated to a temperature of from about 30°C to about 60°C.

-18-
22. The process of Claim 20 wherein the reaction mixture is
filtered after heating.
23. The process of Claim 1 wherein the N-(4-fluorophenyl)-N-(1-
methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy]acetamide is
recovered by acidifying the organic phase removing the solvent from the
organic phase to form a molten material and isolating the
N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thiadiazol-2-
yl)oxy]acetamide from the molten material.
24. A process for preparing N-(4-fluorophenyl)-N-(1-methyl-
ethyl)-2-[(5-trifluoromethyl)-1,3,4-thiadiazole-2-yl)oxy]acetamide comprising
adding 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole in toluene
and N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide in toluene
to a reaction vessel to form a reaction mixture, cooling the reaction
mixture to about 0°C-5°C, adding an aqueous solution of sodium
hydroxide to the reaction mixture and maintaining the reaction mixture at
a temperature of from about 5°C to about 15°C for a period of timeranging from about 1 hour to about 3 hours to form an aqueous phase,
and an organic phase having a pH of from about 8 to about 14, acidifying
the mixture, heating the phases to a temperature of from about 10°C to
about 90°C, filtering the reaction mixture, separating the phases, and
recovering the N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-
1,3,4-thiadiazol-2-yl)oxy]acetamide from the organic phase.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 022~462~ 1998-11-27
Mo4746
MD-93-1 20A-PF
A PROCESS FOR MAKING N-(4-FLUOROPHENYL)-N-(1-
METHYLETHYL)-2-[(5-TRIFLUOROMETHYL)-1 ,3,4-THIADIA,OL-2-
YL)OXY1ACETAMIDE USING AN APROTIC. AROMATIC SOLVENT
Technical Field of the Invention
The field of this invention is the synthesis of acetamide herbicides.
More particularly, this invention relates to processes for making,
recovering and isolating N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-
trifluoromethyl)-1 ,3,4-thiadiazol-2-yl)oxy]acetamide.
BACKGROUND OF THE INVENTION
Certain azolyloxy-carboxylic acid amides and heteroaryloxy-
acetamides of the general formula R-o-CH(R')-Co-N(R2)(R3) are known
to have herbicidal activity (See, e.g., United States Patent Nos.
4,756,741 and 5,101,034). United States Patent No. 5,101,034 discloses
a particular class of heteroaryloxyacetamides, namely thiadiazole
15 acetamides as having herbicidal activity. The thiadiazole acetamides are
made by reacting a thiadiazole sulfone with an hydroxyacetanilide in
acetone. Of particular relevance to the present invention is the
disclosure of a synthetic scheme for making 2-(5-trifluoromethyl)-1,3,4-
thiadiazol-2-yl-oxy)-N-methylacetanilide. In accordance with that
20 synthetic scheme, 2-methylsulfonyl-5-trifluoromethyl-1,3,4-thia~ ole is
reacted with N-methyl-2-hydroxyacetanilide, potassium carbonate, and
tetraethylammonium bromide. Acetone is used as the solvent for the
reaction. The reaction is carried out at a temperature of 20~C - 25~C for
20 hours. Undissolved salts are flltered off and washed with acetone.
25 The filtrate is freed of solvent in vacuo and the resulting residue taken up
in diethyl ether, washed with dilute hydrochloric acid, dried and flltered.
After freeing the filtrate of solvent, the end product is crystallized from the
oily residue. Reported yields are about 90%.
United States Patent Nos. 4,756,741 and 4,645,525 disclose a
30 synthetic scheme for making 0-(2-trifluoromethyl-1,3,4,-thi~r~i~7OI-5-yl-

CA 022~462~ 1998-11-27
.
Mo4746 -2-
oxo)acetic N-methylanilide. In accordance with that scheme, 2-hydroxy-
acetic acid-N-methylanilide is reacted with dimethylsulfoxide and calcium
oxide at 50~C for 1 hour. 5-Bromo-2-trifluoromethyl-1,3,4-thidiazole is
then added to the reaction mixture and the mixture stirred at 50~C for 40
5 hours. The mixture is then poured into water and the oil that precipitates
is extracted with methylene chloride. The end product is obtained in
about 90% yield by distilling off the methylene chloride.
United States Patent No. 4,585,471 discloses synthetic schemes
for making (5-trifluoromethyl-1,3,4-thiadiazol-2-yl-oxy)-acetic acid 2-
10 ethylpiperidine and (5-trHluoromethyl-1,3,4-thi~d~ol-2-yl-oxy)-acetic acid
2-methylpiperidine. In accordance with those synthetic schemes, the
ethylpiperidine compound is made by reacting hydroxyacetic acid-2-
ethylpiperidine with 2-chloro-5-trifluoromethyl-1,3,4-thiadi~ole in the
presence of potassium tert-butanate in tert-butanol at a temperature of
15 20~C to 30~C for 3 hours and the methylpiperidine compound is made by
reacting 2-chloro-5-trifluoromethyl-1,3,4-thi~~ ole in toluene with
hydroxyacetic acid-2-methylpiperidine in the presence of sodium
hydroxide. The end product, in both cases, is recovered from the
reaction mixture by acidiricalion with hydrochloric acid, drying, removal of
20 solvent and crystallization. The reported yields of the end-products were
66% (ethylpiperidine) and 54% (methylpiperidine).
United States Patent Nos. 4,968,342 and 5,090,991 disclose a
synthetic scheme for making N-isopropyl-(5-trifluoromethyl-1,3,4,-
thiadiazol-2-yl)-3'-chlorooxyacetanilide. In accorda,lce with that scheme,
25 2-methylsulfonyl-5-trifluoromethyl-1,3,4-thi~ ole, dissolved in acetone,
with 3'-chloro-N-isopropylhydroxyacetanilide in the presence of sodium
hydroxide and water for 3 hours at -20~C. Water is added to the reaction
mixture and the crystalline end-product obtained by cryst~ tion in 85%
yield.

CA 022~462~ 1998-11-27
A
Mo4746 -3-
lt can be seen from the above, that existing methods for making
acetamide herbicides suffer from low yields (54% to 85%), prolonged
reaction times (20 to 40 hours) or the use of problematic solvents
(acetone). There continues to be a need in the art, therefore, for a
5 practical method for making these herbicides, which method avoids the
problems of the existing art.
BRIEF SUMMARY OF THE INVENTION
The present invention provides a process for prepa,i"g N-(4-
fluorophenyl)-N-(1 -methylethyl)-2-[(5-trifluoromethyl)-1 ,3,4-thiadiazol-2-
10 yl)oxy]acetamide. The process includes the steps of: (a) reacting 2-
(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole with N-(4-
fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide in the presence of an
aprotic, aromatic solvent to form an aqueous phase and an organic
phase; (b) separating the phases; and (c) recovering the N-(4-
15 fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thiadiazol-2-
yl)oxy]acetamide from the organic phase. The solvent is preferably
toluene, xylene, cumene or mesitylene and, more ,~referably toluene. In
a preferred embodiment, reaction occurs in the presence of an aqueous
alkali. The aqueous alkali is preferably an aqueous alkali metal carbonate
20 or an aqueous alkali metal hydroxide where the alkali metal is sodium.
Most preferably, the aqueous alkali is aqueous sodium hydroxide.
As a result of alkali use, the aqueous phase has a pH of from
about 11 to about 14, more preferably a pH of about 13. The reaction of
2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadi~ole with N-(4-fluoro-
25 phenyl)-2-hydroxy-N-(1-methylethyl)acetamide in solvent is carried out at
a temperature of from about 0~C to about 30~C, preferdbly from about
5~C to about 15~C. The molar ratio of 2-(methylsulfonyl)-5-
(trifluoromethyl)-1 ,3,4-thi~~ ole to N-(4-fluorophenyl)-2-hydroxy-N-(1-
methylethyl)acetamide is from about 1.5:1 to about 1:1.5, preferably

CA 022~462~ 1998-11-27
Mo4746 4-
about 1:1. The molar ratio of solvent to 2-(methylsulfonyl)-5-
(trifluoromethyl)-1,3,4-thi~di~ole is from about 1:1 to about 5:1.
In one embodiment, a process of the present invention using
alkali further includes the step of acidifying the aqueous phase before
5 phase separation. The agueous phase is acidified to a pH of from about
2.0 to about 6.0 and preferably to a pH of from about 3.0 to about 5Ø
The reaction mixture is treated with hydrochloric acid or sulfuric acid.
The reaction mixture can be heated to a temperature of from about 10~C
to about 80~C, filtered and the organic and aqueous phases are
10 separated. The N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-
1,3,4-thiadiazol-2-yl)oxy]acetamide is recovered by acidifying the organic
phase, removing the solvent from the organic phase via steam distillation
or vacuum distillation to form a molten mother liquor mixture and isolating
the N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-
15 thiadiazol-2-yl)oxy]acetamide from the molten residue.
In a prefer~ed embodiment, a process for preparing N-(4-
fluorophenyl)-N-(1 -methylethyl)-2-[(5-trifluoromethyl)-1 ,3,4-thiadiazol-2-
yl)oxy]acetamide includes the steps of adding 2-(methylsulfonyl)-5-
(trifluoromethyl)-1,3,4-thiadiazole in toluene and N-(4-fluorophenyl)-2-
20 hydroxy-N-(1-methylethyl)acetamide in toluene to a reaction vessel,
cooling the reaction mixture to about 0~C-5~C, adding an aqueous
solution of sodium hydroxide and maintaining the reaction mixture at a
temperature of from about 5~C to about 1 5~C for a period of time ranging
from about 1 hour to about 3 hours to form an aqueous phase, an
25 alkaline rag phase and an organic phase having a pH of from about 11 to
about 14, acidifying the aqueous phases, heating the phases to a
temperature of from about 10~C to about 20~C, filtering the reaction
mixture, separating the phases, and recovering the N-(4-fluorophenyl)-N-

CA 022~462~ 1998-11-27
Mo4746 5
(1 -methylethyl)-2-[(5-trifluoromethyl)-1 ,3,4-thiadiazol-2-yl)oxy]acetamide
from the organic phase.
DETAILED DESCRIPTION OF THE INVENTION
1. The Invention
The present invention relates to processes for the synthesis,
recovery and isolation of the herbicide, N-(4-fluorophenyl)-N-(1-
methylethyl)-2-[(5-trifluoromethyl)-1 ,3,4-thiadiazol-2-yl)oxy]aceta,) ,ide.
The synthetic process includes the step of reacting 2-(methylsulfonyl)-5-
(trifluoromethyl)-1,3,4-thiadiazole with N-(4-fluorophenyl)-2-hydroxy-N-(1-
10 methylethyl)acetamide and aqueous NaOH in the presence of an aprotic,
aromatic solvent. Formed N-(4-fluorophenyl)-N-(1-methylethyl)-2-~(5-
trifluoromethyl)-1,3,4-thi~di~ol-2-yl)oxy]acetamide can be recovered after
acidification followed by phase separation and removal of solvent from
the organic phase.
15 Il. Method of Makina N-(4-fluorophenyl)-N-(1-methylethvl)-2-~(5-
trifluoromethvl)- 1.3.4-thiadiazol-2-yl)oxvlacetamide Usin~ an Aprotic.
Aromatic Solvent
The process for making N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-
trifluoromethyl)-1,3,4-thi~tiia~ol-2-yl)oxy]acetamide includes the step of
20 reacting 2-(methylsulfonyl)-5-(trifluoromethyl)-1 ,3,4-thi~di~7Ole with N-(4- fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide in an aprotic,
aromatic solvent. The solvent is preferably toluene, xylene, cumene or
mesitylene and, most preferably toluene.
The 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thi~ ole (TDA
25 sulfone) and the N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)-
acetamide (FOE hydroxy) used in the present process can be made
using any method. P,ererled means for making TDA sulfone can be
found in United States Patent Applications entitled USynthesis of
Sulfoxides Using Controlled Oxidation of Sulfides with Perborate or

CA 022~462~ 1998-11-27
Mo4746 -6-
Percarbonate ", USynthesis of 2-(Methylsulfonyl)-5-(TrKluoromethyl)-1,3,4-
Thiadiazole Using Oxidation of 2-(Methylthio)-5-(Trifluoromethyl) -1,3,4-
Thiadiazole with a Molybdenum or Tungsten Catalyst ", and USynthesis of
2-(Methylsulfonyl)-5-(Trifluoromethyl)-1,3,4- Thi~ ole Using Oxidation
5 of 2-(Methylthio)-5-(Trifluoromethyl)-1,3,4-Thiadiazole with Acetic AcidU,
filed concurrently herewith. Preferred means for making FOE hydroxy
can be found in United States Patent Applications entitled UConversion of
N-(4-Fluorophenyl)-2-Hydroxy-N-(1-Methylethyl) Acetamide Acetate to N-
(4-Fluorophenyl)-2-Hydroxy-N-(1-Methylethyl) Acetamide Using Aqueous
10 Alkali," "Method of Making N-(4-Fluorophenyl)-2-Hydroxy-N-(1-Methylethyl
Acetamide Using Sodium Formate," and "Conversion of N-(4-Fluoro-
phenyl)-2-Hydroxy-N-(1-Methylethyl) Acetamide Acetate to N-(Fluoro-
phenyl)-2-Hydroxy-N-(1-Methylethyl) Acetamide Using Water and
Solvent," filed concurrently herewith. The disclosures of all five of these
15 patent applications are incorporated herein by refere,)ce. The molar ratio
of 2-(methylsulfonyl)-5-(trifluoromethyl)-1 ,3,4-thiadi~ole to N-(4-fluoro-
phenyl)-2-hydroxy-N-(1-methylethyl)acetamide is from about 1.5:1 to
about 1:1.5 and more preferably about 1:1.
Where the TDA sulfone and FOE hydroxy are not provided in the
20 solvent, the solvent is added to the reaction mixture. The molar ratio of
solvent (e.g., toluene) to either TDA sulfone or FOE hydroxy is from
about 1:1 to about 5:1. The solvent is preferably present in a molar
excess relative to TDA sulfone and FOE hydroxy. The reaction
preferably uses purified reactants. As set forth hereinafter in the
25 Examples, the use of highly purified TDA sulfone and FOE hydroxy
results in enhanced purity and yield of N-(4-fluorophenyl)-N-(1-
methylethyl)-2-[(5-trifluoromethyl)-1 ,3,4-thiadiazol-2-yl)oxy]acetamide.
The purity of the TDA sulfone is preferably greater than about 95% A.l.,
more preferably greater than about 97.5% A.l. and, even more preferably

CA 022~462~ 1998-11-27
Mo4746 7
greater than about 99.0% A.l. The purity of the FOE hydroxy is
preferably greater than about 94.0% A. I., more preferdbiy greater than
about 96.0% A.l., even more preferably greater than about 98.0% A.l.
and, most preferably greater than about 99.0% A.l.
The reaction of TDA sulfone and FOE hydroxy typically occurs at
a relatively cool temperature. Preferably the reaction temperature is from
about 0~C to about 30~C. More preferably, the temperature is from about
0~C to about 1 5~C and, most preferably from about 0~C to about 5~C.
In a preferred embodiment, the reaction occurs in the presence of
10 an aqueous alkali. Exemplary and preferred aqueous alkalis are aqueous
alkali metal hydroxides or carbonates. Alkali metal hydroxides and
carbonates are well known in the art. Exemplary and pr~fer,~d alkali
metals are potassium, sodium and lithium. Sodium is most preferred.
The molar ratio of the aqueous alkali (e.g., sodium hydroxide) to the
15 primary reactants (e.g., TDA sulfone and FOE hydroxy) is from about 1:1
to about 2:1 and, preferably from about 1.25:1 to about 1.75:1. The
aqueous alkali is added to the reaction mixture as an aqueous solution of
the hydroxide or carbonate. Plererably the alkali metal hydroxide or
carbonate concentration of the solution is from about 20 weight percent
20 to about 60 weight percent. More prererably, the alkali conce"l,alion is
from about 25 weight percent to about 50 weight peroent.
The aqueous alkali can be added at a single time or added in
portions over a ,urolonged period of time. The yield and purity of the
formed N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-
25 thiadiazol-2-yl)oxy] acetamide is enhanced where the alkali is added
slowly over a period of from about 1 hour to about 3 hours. The mixture
of TDA sulfone and FOE hydroxy is agitated during the entire time over
which the alkali is added.
In an especially preferred embodiment, the process includes the

CA 022~462~ 1998-11-27
Mo4746 -8-
steps of adding 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thiadiazole in
toluene and N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide in
toluene to a reaction vessel to form a reaction mixture, cooling the
reaction mixture to about 0~C-5~C, adding an aqueous solution of sodium
hydroxide to the reaction mixture slowly over 1 to 3 hours and
maintaining the reaction mixture at a temperature of from about 0~C to
about 5~C for a period of time ranging from about 1 hour to about 3
hours.
A sufficient amount of alkali is used so as to raise the pH of the
10 aqueous phase to a pH of from about 1 1 to about 14. Preferably, the pH
is raised to a level of from about 12 to about 14. Means for determining
the amount of a particular alkali needed to cause such an increase in pH
are well known in the art.
The process can further include the step of recovering the N-(4-
15 fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thi~1i~701-2-
yl)oxy] acetamide. Recovery can be accomplished using any well known
recovery method. Preferably, recovery is accomplished using acid as set
forth below. A process of the present invention produces N-(4-fluoro-
phenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thi~ ii~ol-2-yl)oxy]
20 acetamide in yields of greater than about 90% (based on either TDA
sulfone or FOE hydroxy) with a purity of over 90% A.l.
Ill. Recoverv of N-(4-fluorophenyl)-N-(1-methvlethyl)-2-~(5-trifluoro-
methyl)-1.3.4-thi~di~ol-2-vl)oxy1acetamide via Acidification Before Phase
Separation
In an especially preferl~d embodiment, N-(4-fluoropl1enyl)-N-(1-
methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thi~di~701-2-yl)oxy]acetamide is
made and recovered accGrdi, ,9 a process that includes the steps of
adding 2-(methylsulfonyl)-5-(trifluoromethyl)-1,3,4-thindi~701e in toluene
and N-(4-fluorophenyl)-2-hydroxy-N-(1-methylethyl)acetamide in toluene

CA 022~462~ 1998-11-27
Mo4746 -9-
to a reaction vessel to form a reaction mixture, cooling the reaction
mixture to about 0~C-5~C, adding an aqueous solution of sodium
hydroxide to the reaction mixture and maintaining the reaction mixture at
a temperature of from about 0~C to about 15~C for a period of time
5 ranging from about 1 hour to about 3 hours to form a reaction product.
It may be desirable to convert the reaction mixture to an acid pH
prior to isolation of the FOE. In accordance with this embodiment, the
phases are treated with acid before phase separation. Preferably, the pH
is lowered to a value of from about 2.0 to about 6.0 and, more prererably,
10 to a value of from about 3.0 to about 5Ø
Acidification is accomplished by treating the reaction mixture with
a suitable amount of mineral acid. Means for determining the amount of
acid needed are well known in the art and will depend, jnter alia, on the
acid used. Suitable mineral acids include sulfuric acid, hydrochloric acid
15 and nitric acid. Hydrochloric and sulphuric acid are most preferred.
Following acidification, the phases are separated and the process
continues as set forth above in Section lll.
The organic phase containing the N-(4-fluorophenyl)-N-(1-
methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thi~di~ol-2-yl)oxy]acetamide is
20 acidified to a pH of from about 1.5 to about 4.5, more prererably to a pH
of from about 1.5 to about 3.0 and, even more preferably to a pH of from
about 1.5 to about 2.5. Means for determining the amount of acid
needed to acidify the organic phase are well known in the art.
Acidification is accomplished by adding a concentrated mineral acid to
25 the organic phase. Suitable mineral acids are hydrochloric acid, nitric
acid and sulfuric acid. Sulfuric acid is prerer,ed. The concer,l,dLion of
sulfuric acid is preferably about 70 weight percent.
N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1 ,3,4-
thiadiazol-2-yl)oxy]aceta~ide can be recovered from the acidified organic

CA 022~462~ 1998-11-27
Mo4746 -1 0-
phase using any means well known in the art. Exemplary such recovery
means include flaking, distillation, extraction and crystallization. A
preferred means of recovery is flaking as described below. As set forth
hereinafter in the Examples, recovery using acidiricaliol, results in yields
5 of greater than about 90%.
IV. Isolation of N-(4-fluorophenyl)-N-(1 -methYlethyl)-2-~(5-trifluoro-
methyl)-1 ,3.4-thiadiazol-2-yl)oxylacetamide
In another aspect, the present invention provides a process for
isolating N-(4-fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-
10 thiadiazol-2-yl)oxy]acetamide. In accordance with this process, N-(4-
fluorophenyl)-N-(1-methylethyl)-2-[(5-trifluoromethyl)-1,3,4-thi~ ol-2-
yl)oxy]acetamide, obtained by any means, is dissolved or suspended in
an aprotic, aromatic solvent such as toluene and isolated from the
toluene. Isolation is typically accomplished by removing the solvent from
15 the solution of N-(4-fluorophenyl)-N-(1-methylethyl)-2-[5-trifluoro-methyl)-
1,3,4-thiadiazol-2-yl)oxy]acetamide to form a solvent-free material.
Melting the material, spreading the molten material out on a solid surface
and allowing the product to crystallize.
Solvent can be removed from the solution using any means well
20 known in the art. A preferred means of solvent removal is evaporaliol1.
Preferably, evaporation is preformed under a negative pressure using a
vacuum apparatus. Evaporation typically occurs at a temperature of from
about 60~C to about 85~C. The molten materials is then spread out in a
thin layer on a solid surface, cooled to a temperature of from about 20~C
25 to about 30~C (room temperature) and maintained at that temperature
until cryst~ tion. The product crystallizes as aggregates of flakes on
the cooled solid surface.

CA 022~462~ 1998-11-27
Mo4746 -1 1-
The Examples to follow illustrate preferred embodiments of the
present invention and are not limiting of the claims and specification in
any way.
ExamPle 1 Synthesis of N-(4-fluorophenYI)-N-(1-methvlethyl)-2-[(5-
trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy~acetamide-
(Fluthiamide)
Dry FOE Hydroxy, dry TDA sulfone, recycled toluene were added
to a reaction vessel. NaOH was slowly added over time to the vessel.
The reaction mixture was then heated over time. The reaction conditions
10 varied over ranges as shown in the Table below.
Toluene/FOE-hydroxy Mole Ratio 5.90~.60
TDAS/FOE-hydroxy Mole Ratio 1.00-1.15
NaOH/FOE-hydroxy Mole Ratio 1.25-1.75
NaOH Conce"lralion (wt. percel1t) 25-50
NaOH Add Time 1-3 hours
Reaction Temperature 5 -1 5~C
Reaction Time 1-3 hours
Example 2 Recovery of Fluthiamide Usin~ Acid
Fluthiamide, produced in accordance with Example 1, was
20 recovered using acid. The reaction mixture from Example 1 was charged
with process water and sulfuric acid (70%) to the desired pH. The
temperature was adjusted and the mixture was filtered. The phases
were then separated.
The above reaction and phase separalio" procedures resulted in
25 an acidic organic mixture of fluthiamide in toluene. Isolation of
fluthiamide was accomplished by two different methods. In a first
method, toluene was removed by batch atmospheric steam distillation
leaving a mixture of molten fluthiamide in water. Fluthiamide was isolated

CA 022~462~ 1998-11-27
Mo4746 -1 2-
via solidification and filtration and drying. This method produced
fluthiamide with an average A.l of about 92%.
In a second method, toluene was removed by batch atmospheric
steam distillation leaving a mixture of molten fluthiamide in water. The
5 bottom, heavy phase was separated. Fluthiamide was isolated from the
heavy organic phase via flaking. This method produced fluthiamide with
an average A.l. of about 88%.
ExamPle 3 Synthesis of N-(4-fluorophenvl)-N-(1-methvlethyl)-2-
~trifluoromethyl)-1 .3.4-thiadiazol-2-yl)oxY~acetamide
1 0 (Fluthiamide)
In a second series of studies, fluthiamide was made by adding dry
FOE Hydroxy, TDA sulfone in toluene, and recycled toluene to a reaction
vessel. NaOH was slowly added over time and the resulting mixture
heated for a period of time. The reaction conditions are set forth below.
Toluene/FOE-hydroxy Mole Ratio 6.00
TDAS/FOE-hydroxy Mole Ratio 1.00-1.03
NaOH/FOE-hydroxy Mole Ratio 1.30-1.35
NaOH Concer,lldlion 50 wt. %
NaOH Add Time 3 hours
Reaction Temperature 10 -15~C
Reaction Time 0-1 hours
Recovery of fluthiamide was accomplished as set forth below:
ExamPle 4 Recovery Usina Sulfuric Acid
In accordance with the hot sulfuric acid process, soft water and
25 70% sulfuric acid were charged to the reaction mixture from Example 3,
above. The phase separation conditions are summarized in the following
table.

CA 022~462~ 1998-11-27
-
- Mo4746 -13-
H2O/FOE-hydroxy wt. ratio 1.10
Phase Separation pH 2.5
Phase Separation Temp 70~C
Filtration yes
Mode continuous
The fluthiamide in toluene was retained for fluthiamide isolation.
The H2SO4 aqueous phase was neutralized and send to a waste water
system.
Example 5 Isolation of Fluthiamide Using Solidiricalion
The organic phase from Example 4 were used for isolation of
fluthiamide. Toluene was removed from the phases using a continuous
atmospheric steam strip in a packed column. The toluene was recycled
to the TDA sulfone and fluthiamide reactions. After removal of the
toluene, fluthiamide was left as a molten fluthiamide/aqueous mixture (the
bottom, heavy phase). The fluthiamide was obtained from the bottom
heavy phase via solidification in a tray.
Example 6 Preparation of Fluthiamide Usin~ Acid Before Phase
SeParation
Embodiment 1
0.25 Moles of TDA-sulfone, 0.25 moles of FOE-hydroxy and 1.085
moles of toluene were mixed together and cooled to 5~C. 0.3 Moles of
sodium hydroxide in the form of a 40 weight percent solution was added
to the reaction mixture over a 1 hour period of time. The temperature of
the reaction mixture was maintained between 5~C and 10~C for about 2
hours. The resulting reaction mixture was acidified to a pH of 5.0 with 10
weight percent HCI. The aqueous and organic layers were separaled.
The aqueous layer was extracted with toluene and the toluene extract
added to the organic layer. The final product, fluthiamide, was isolated
using flaking after removal of the toluene. Fluthiamide produced in

CA 022~462~ 1998-11-27
Mo4746 -1 4-
accordance with this embodiment had a purity of 97.1% A.l. and a net
yield of 99%.
Embodiment 2
About 17 moles of toluene, 3 moles of TDA-sulfone and 3 moles
of FOE- hydroxy were mixed together and cooled to a temperature of
5~C. 450 ml of a 25 weight percent aqueous solution of sodium
hydroxide was added to the mixture over a 1 hour period of time. About
270 ml of water and 85.8 grams of a 70 weight percent solution of H2SO4
was added to the reaction mixture to decrease the pH from a value of 13
10 to a value of 2.8. The reaction mixture was then heated to a temperature
of 45~C and held at that temperature for 15 minutes. The reaction
mixture was stirred and heated to 65~C for about 30 minutes. 50 mls of
water was added to the mixture and the mixture heated to 85~C. After
two hours, the reaction mixture was filtered and the aqueous and organic
15 phases separated. Toluene was stripped off the organic layer and
fluthiamide isolated using flaking. Fluthiamide prepared in accordance
with this embodiment, had a purity of 99.3 % A.l. and a net yield of
99.6%.
Embodiment 3
About 3 moles of toluene, 0.5 moles of TDA-sulfone and 0.5 moles
of FOE- hydroxy were mixed together and cooled to a temperature to a
5~C. 96 grams of a 25 weight percent sodium hydroxide solution was
added over a period of time of 1 hour while maintaining the temperature
at 5~C. Following the ~dd;tioll of sodium hydroxide, the reaction mixture
25 was heated for an additional 1.5 hours at 5~C . The reaction mixture was
then titrated with 16.3 grams of concentrated HCI and quenched with 55
grams of water. Following the addition of acid and water, the reaction
mixture was heated to a temperature of 45~C for 1.5 hours. The
temperature was then increased to 65~C and maintained at this

CA 022~462~ 1998-11-27
Mo4746 -1 5-
temperature for an additional 35 minutes. The temperature of the
reaction mixture was then increased to 85~C and maintained at this
temperature for about 15 to 20 minutes. The reaction mixture was
cooled, filtered, and the organic and aqueous layers were separ~ed.
5 Fluthiamide was isolated from the organic layer by distilling off the
toluene and isolating fluthiamide using flaking. When prepared in
accordance with this embodiment, fluthiamide had with a purity of 96.9%
A.l. and a net yield of 97.7 %.
Although the invention has been described in detail in the
10 foregoing for the purpose of illustration, it is to be understood that such
detail is solely for that purpose and that varidlio"s can be made therein
by those skilled in the art without departing from the spirit and scope of
the invention except as it may be limited by the claims.

Representative Drawing

Sorry, the representative drawing for patent document number 2254625 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-12
Application Not Reinstated by Deadline 2004-11-29
Time Limit for Reversal Expired 2004-11-29
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 2003-11-27
Inactive: Abandon-RFE+Late fee unpaid-Correspondence sent 2003-11-27
Inactive: Cover page published 1999-07-02
Application Published (Open to Public Inspection) 1999-06-12
Classification Modified 1999-02-02
Inactive: First IPC assigned 1999-02-02
Inactive: IPC assigned 1999-02-02
Inactive: Filing certificate - No RFE (English) 1999-01-08
Application Received - Regular National 1999-01-07

Abandonment History

Abandonment Date Reason Reinstatement Date
2003-11-27

Maintenance Fee

The last payment was received on 2002-10-25

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Fee History

Fee Type Anniversary Year Due Date Paid Date
Application fee - standard 1998-11-27
Registration of a document 1998-11-27
MF (application, 2nd anniv.) - standard 02 2000-11-27 2000-11-01
MF (application, 3rd anniv.) - standard 03 2001-11-27 2001-10-30
MF (application, 4th anniv.) - standard 04 2002-11-27 2002-10-25
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BAYER CORPORATION
Past Owners on Record
DANIEL M. WASLESKI
JACQUELINE M. APPLEGATE
KLAUS JELICH
PETER E. NEWALLIS
VIDYANATHA A. PRASAD
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 1998-11-26 15 657
Abstract 1998-11-26 1 24
Claims 1998-11-26 3 110
Courtesy - Certificate of registration (related document(s)) 1999-01-07 1 115
Filing Certificate (English) 1999-01-07 1 163
Reminder of maintenance fee due 2000-07-30 1 110
Reminder - Request for Examination 2003-07-28 1 112
Courtesy - Abandonment Letter (Request for Examination) 2004-02-04 1 168
Courtesy - Abandonment Letter (Maintenance Fee) 2004-01-21 1 176